Plaque Psoriasis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Plaque Psoriasis Market is segmented By Treatment (Systemic Therapies, Topical Therapies, Phototherapy), By Severity (Mild Plaque Psoriasis, Moderate ....
Competitive overview of Plaque Psoriasis Market
The major players operating in the plaque psoriasis market include AbbVie Inc., Novartis International AG, Johnson & Johnson (Janssen Pharmaceuticals), Eli Lilly and Company, Amgen Inc., Celgene Corporation (a Bristol Myers Squibb company), Pfizer Inc., UCB S.A., Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Dermavant Sciences GmbH, IQVIA Biotech, Samsung Bioepis Co., Ltd, Durect Corporation, Astellas Pharma Inc., Biogen, Dow Pharmaceutical Sciences, Shire plc, Zalicus Inc., Santalis Pharmaceuticals Inc, Maruho Co Ltd., and AstraZeneca plc.
Plaque Psoriasis Market Leaders
- AbbVie Inc.
- Novartis International AG
- Johnson & Johnson (Janssen Pharmaceuticals)
- Eli Lilly and Company
- Amgen Inc.
*Disclaimer: Major players are listed in no particular order.
Plaque Psoriasis Market - Competitive Rivalry, undefined
Plaque Psoriasis Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights